Chris Francis, See Remarks at Wave Life Sciences Ltd. (WVE), sold 274,461 shares at $13.00 ($3.8M) on 2024-10-16, disclosed to the SEC on 2024-10-18.
Scheduled sale ($3.8M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 40,997 | $533K | 14.2% |
| 2 | $13.50 | 22,500 | $304K | 8.1% |
| 3 | $13.75 | 65,625 | $902K | 24.0% |
| 4 | $13.75 | 65,625 | $902K | 24.0% |
| 5 | $14.00 | 79,714 | $1.1M | 29.7% |
| Total | $13.69 avg | 274,461 |
| $3.8M |
| 100% |
| Filing → |
| WVE | SELL | 2026-01-06 | $150K | — | Filing → |
| WVE | SELL | 2025-12-10 | $8.6M | — | Filing → |
| WVE | SELL | 2024-11-13 | $576K | — | Filing → |